A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies
A phase 2 trial of Domvanalimab, Quemliclustat, Zimberelimab and Oxaliplatin in advanced solid tumours, run by Arcus Biosciences, Inc., active and no longer recruiting.
Overview
A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies is a phase 2 interventional study registered as NCT05329766 by Arcus Biosciences, Inc., with 332 participants enrolled, started 2022-06-10 and due to reach its primary completion in 2027-01. Interventions recorded: Domvanalimab, Quemliclustat, Zimberelimab, Fluorouracil, Leucovorin and Oxaliplatin.
Similar pages
not linked directly; found by shared links- TrialImmuno-Oncology Drugs GLS-012 Alone & in Combination GLS-010 Treating With Advanced Patients Solid Tumors
Shares Zimberelimab, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialStudy of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
Shares Zimberelimab, Gilead Sciences (incl. Kite) and the tag pipeline.
- TrialStudy of Sacituzumab Govitecan in Participants With Metastatic Solid Tumors
Shares Gilead Sciences (incl. Kite), Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialStudy of Sacituzumab Govitecan in Patients With Solid Tumor
Shares Gilead Sciences (incl. Kite), Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialEvaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer
Shares Oxaliplatin, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
Shares Oxaliplatin, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]
Shares Oxaliplatin, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialClinical Studies for the Treatment of Advanced Solid Tumors
Shares Oxaliplatin, Metastatic cancer (cancer that has spread) and the tag pipeline.